Vice President Kamala Harris on the campaign trail has frequently touted capping the price of insulin at $35 a month as a ...

And that problem is not unique to insulin. PBMs demand rebates and other payments from pharmaceutical companies as a condition of favorable placement for a medicine on the formulary, or list of ...

In its complaint, the FTC alleges that PBMs followed a “chase-the-rebate strategy,” which led to soaring insulin list prices and made it harder for Americans to get the crucial medication ...

Improving the Patient Financial Experience Throughout the Patient Journey While many healthcare providers believe that improving the patient financial experience is a critical step for their ...

in the US for operating a "perverse drug rebate system" that it claims artificially inflated the prices of insulin products. The lawsuit – which has been anticipated since the FTC published a ...

The drug gatekeepers favored versions of insulin with higher upfront prices and bigger rebate payments from pharmaceutical companies, which shifted more costs onto patients, the FTC alleged.

INSULIN LITIGATION DEEP-DIVE — As Congress ... The counties say their contracts require that rebates the PBMs negotiate with manufacturers must “pass through” to them, which payers can ...

Some diabetes patients this year have had trouble finding their preferred insulin brands as major drug manufacturers reported shortages of the medicine. USA TODAY set out to find out what patients ...

No matter what happens in this election, the government should work for the people. The government may not be perfect, but it ...

The FTC accuses major PBMs of inflating insulin prices, impacting patient costs and access to affordable medications. PBMs prioritize high-rebate drugs, contributing to high insulin prices and ...

The Federal Trade Commission took action Friday against the nation’s three largest pharmacy benefit managers, accusing the ...

The US Federal Trade Commission sued units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. on Friday, accusing the drug middlemen of engaging in illegal rebate programs that drove up the ...